Should we apply?
7 questions about Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed). The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.